Ionis Pharmaceuticals Inc (NASDAQ: IONS) stock closed at $42.39 on 9/10/24 after a major decline of -12.3%. Moreover, exceptionally high trading volume at 838% of normal accompanied the decline. The stock has declined -11.1% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
IONS is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Ionis Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Ionis Pharmaceuticals has a poor Power Rating of 28 and a very low Appreciation Score of 3, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment